Search Results

Filter
  • 1-10 of  65,772 results for ""Osteoprotegerin""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Serum osteoprotegerin and its gene polymorphisms in patients with Takayasu's arteritis: a bicentric cross-sectional study.

Subjects: Takayasu Arteritis*/Takayasu Arteritis*/Takayasu Arteritis*/genetics ; Takayasu Arteritis*/Takayasu Arteritis*/Takayasu Arteritis*/blood ; Osteoprotegerin*/Osteoprotegerin*/Osteoprotegerin*/blood

  • Source: Advances in rheumatology (London, England) [Adv Rheumatol] 2024 May 28; Vol. 64 (1), pp. 43. Date of Electronic Publication: 2024 May 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101734172 Publication Model: Electronic Cited Medium: Internet ISSN: 2523-3106

Record details

×
Academic Journal

Association of Serum Osteoprotegerin With Vascular Calcification, and Cardiovascular and Graft Outcomes in Kidney Transplant Patients: Results From the KNOW-KT.

Subjects: Kidney Transplantation*/Kidney Transplantation*/Kidney Transplantation*/adverse effects ; Osteoprotegerin*/Osteoprotegerin*/Osteoprotegerin*/blood ; Vascular Calcification*/Vascular Calcification*/Vascular Calcification*/blood

  • Source: Transplantation [Transplantation] 2024 May 01; Vol. 108 (5), pp. 1239-1248. Date of Electronic Publication: 2024 Jan 31.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0132144 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

LMS-based continuous pediatric reference values for soluble receptor activator of nuclear factor kappa B ligand (sRANKL) and osteoprotegerin (OPG) in the HARP cohort.

  • Authors : Tietze H; Department of Pediatric Kidney, Liver and Metabolic Diseases, Pediatric Research Center, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.; Pott V

Subjects: Carrier Proteins* ; Cytokines* ; Osteoprotegerin*

  • Source: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA Publisher: Springer International Country of Publication: England NLM ID: 9100105 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Salivary levels of Osteoprotegerin and receptor activator of nuclear factor-kappa ligand during orthodontic tooth movement-A prospective pilot study.

  • Authors : Naoumova J; Department of Orthodontics, Institute of Odontology, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.; Specialist Clinic for Orthodontics, Gothenburg, Public Dental Service, Region Västra Götaland, Sweden.

Subjects: Osteoprotegerin* ; Tooth Movement Techniques*; Female

  • Source: Orthodontics & craniofacial research [Orthod Craniofac Res] 2024 Feb; Vol. 27 (1), pp. 78-83. Date of Electronic Publication: 2023 Jun 29.Publisher: Blackwell Munksgaard Country of Publication: England NLM ID: 101144387 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Reliability, stability during long-term storage, and intra-individual variation of circulating levels of osteopontin, osteoprotegerin, vascular endothelial growth factor-A, and interleukin-17A.

Subjects: Osteopontin* ; Osteoprotegerin*; Humans

  • Source: European journal of medical research [Eur J Med Res] 2024 Feb 17; Vol. 29 (1), pp. 133. Date of Electronic Publication: 2024 Feb 17.Publisher: BioMed Central Country of Publication: England NLM ID: 9517857 Publication Model: Electronic Cited Medium: Internet ISSN: 2047-783X

Record details

×
Academic Journal

Correlates of Circulating Osteoprotegerin in Women with a Pathogenic or Likely Pathogenic Variant in the BRCA1 Gene.

  • Authors : Park SS; Department of Nutritional Sciences, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.; Women's College Research Institute, Women's College Hospital, Toronto, Canada.

Subjects: Genes, BRCA1* ; Osteoprotegerin*/Osteoprotegerin*/Osteoprotegerin*/genetics; Adult

  • Source: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9200608 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Osteoprotegerin and receptor activator of the nuclear factor kappa B ligand (RANKL) in healthy pubertal girls - relationships with physical growth and classical bone turnover markers.

Subjects: Bone and Bones*/Bone and Bones*/Bone and Bones*/metabolism ; Osteoprotegerin*/Osteoprotegerin*/Osteoprotegerin*/metabolism; Adolescent

  • Source: Journal of physiology and pharmacology : an official journal of the Polish Physiological Society [J Physiol Pharmacol] 2024 Feb; Vol. 75 (1). Date of Electronic Publication: 2024 Publisher: Polish Physiological Society Country of Publication: Poland NLM ID: 9114501 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Report

The association of osteoprotegerin and RANKL with osteoporosis: a systematic review with meta-analysis.

  • Authors : Chi G; Department of Orthopedics, Hanzhong Central Hospital, Hanzhong City, 723000, Shanxi Province, China.; Qiu L

Subjects: Osteoprotegerin* ; Osteoporosis*; Humans

  • Source: Journal of orthopaedic surgery and research [J Orthop Surg Res] 2023 Nov 07; Vol. 18 (1), pp. 839. Date of Electronic Publication: 2023 Nov 07.Publisher: BioMed Central Country of Publication: England NLM ID: 101265112 Publication Model: Electronic Cited Medium: Internet ISSN: 1749-799X

Record details

×
Academic Journal

Effects of low-level laser on the expression of interleukin-6, tumor necrosis factor‑α, osteoprotegerin, and receptor activator of nuclear factor-κB ligand in human periodontal ligament cells.

  • Authors : Tang M; Dept. of Orthodontics, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.; Cui ZQ

Subjects: Osteoprotegerin* ; Tumor Necrosis Factor-alpha*/Tumor Necrosis Factor-alpha*/Tumor Necrosis Factor-alpha*/metabolism; Humans

  • Source: Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology [Hua Xi Kou Qiang Yi Xue Za Zhi] 2023 Oct 01; Vol. 41 (5), pp. 521-532.Publisher: Sichuan yi xue yuan Country of Publication: China NLM ID: 9422648 Publication Model: Print Cited Medium: Internet ISSN: 2618-0456

Record details

×
Academic Journal

RANKL/RANK is required for cytokine-induced beta cell death; osteoprotegerin, a RANKL inhibitor, reverses rodent type 1 diabetes.

  • Authors : Kondegowda NG; Department of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes and Metabolism Research Institute, City of Hope, Duarte, CA 91010, USA.; Diabetes, Obesity, and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Subjects: Osteoprotegerin*/Osteoprotegerin*/Osteoprotegerin*/metabolism ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy; Humans

  • Source: Science advances [Sci Adv] 2023 Nov 03; Vol. 9 (44), pp. eadf5238. Date of Electronic Publication: 2023 Nov 01.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic

Record details

×
  • 1-10 of  65,772 results for ""Osteoprotegerin""